Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

After a wild day yesterday once we realised Continental had mysteriously and unaccountably changed our flights to Stockholm from Weds to Weds to Thurs to Tues, it seems that Cinderella will be going to the ball after all.

European Multidisciplinary Cancer Conference (EMCC) here we come, whew!

There are a couple of sessions I’m particularly looking forward to this year:

    1. Presidential Symposium on Sat 25th with talks from some of the leading lights in translational research:
      • Tak Mak (U Toronto) on metabolism and cancer
      • Jose Baselga (MGH) on the challenges of personalised medicine
      • Gordon Mills (MDACC) on the future of personalised medicine

 

    1. Various abstract highlights include:
      • Update on phase II ERIVANCE data for the Hedgehog inhibitor, vismodegib, in basal cell carcinoma (see phase I data from AACR)
      • Biomarkers, including VEGF-A in the bevacizumab trials and an update on KRAS
      • Phase II T-DM1 (trastuzumab emtansine) data in breast cancer
      • Reversing drug resistance in breast cancer (Mon 27th)
      • Updated data from the phase I and III (BRIM3) studies of vemurafenib (Zelboraf) in BRAF V600E-mutation positive metastatic melanoma (will be interesting to see how this compares to the ASCO data
      • Update on therapies in prostate cancer, including new phase III Alpharadin data (see Biotech Strategy Blog)

 

  1. Scientific symposia on PARP inhibitors and PI3K inhibitors (both on Tues 28th). I’m gutted these two important sessions clash, as they are both key events I’d love to attend :(

All in all, it promises to be a fun and interesting meeting. For those interested, here’s the link to the full details of the EMCC programme.

Social media comes to ECCO

 

The official Twitter hashtag of the meeting is #emcc2011, a bit long I know, and I would much rather have the shorter, more descriptive and well known #ECCO or #ESMO, but it is a three organisation event afterall, with ECCO, ESMO and ESTRO all involved. You can also follow the EMCC conference organisers on Twitter (@EuropeanCancer).

This inevitably creates branding issues given it seems everyone in the industry has been seemingly asking me over the last two weeks if I’m going to ECCO or ESMO in equal measures! None outside of Twitter have mentioned EMCC at all. Ah well.

9 Responses to “What’s hot at ECCO, ESMO, EMCC in Stockholm 2011?”

  1. Dixon Vacation

    Hey, thanks for giving this information about all those events. I was absolutely out aware of all this! Now I will try to visit one or two!
    Dream Vacation

    • maverickny

      I’m very much looking forward to the BOLERO-2 data and think it will be one of the highlights of the meeting after hearing recently that the interim data was excellent.

      Didn’t want to spoil all the fun stuff up front though :)

      • Raji

        Great!! I’ll be looking forward to your tweets and posts… Have a good trip!!

  2. Kathi Apostolidis

    May I add to the Social Media comes to ECCO section of your post that the social is not only twitter and facebook accounts but most important a teaching lecture and session on Cancer and the Internet/Patient Advocacy & Ethics track.
    The teaching lecture on how health professionals and patient groups are using social media will be held on Sunday Sept. 25 at 8.00-8.45a.m. at Hall T6. and the session on Cancer and the Internet will be held at 13.15-14.15p.m.
    Looking forward to meet you there

  3. boz

    Kids, enjoy eating and regular tooth brushing habits in time the price of sugar, rotten teeth in their mouths they pay later in life.health insurance Preventive dentistry is a new practice in the fissure, is an effective method to prevent children’s tooth decay.health video

    Completes the development of the real teeth instead of milk teeth, bruises to avoid being referenced fissure sealant application. In this application, hair, teeth, toothbrush, clean in the deep fissures and potholes because of the closure is based on ingress.health

  4. Hector

    It’s such a bummer I missed this event. I hope it’s on annual basis so I can attend next year!

Comments are closed.

error: Content is protected !!